Physician Dispensed Cosmeceuticals Market Size, Share, Growth Analysis, By Product Type(Skin Care, Hair Care, Eye Care, Other Product Types), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Region - Industry Forecast 2024-2031

Physician Dispensed Cosmeceuticals Market was valued at USD 8.5 Billion in 2022, and USD 9.16 billion in 2023 and it is expected to reach a value of USD 16.7 Billion by 2031, at a CAGR of 7.8% over the forecast period (2024-2031).

Physician-dispensed cosmeceuticals are products that are only available through a medically guided company and are designed to produce true biological effects below the stratum corneum on the skin. Medicated aesthetic goods suggested by dermatologists, trichologists, cosmetic surgeons, and other medical practitioners are described as physician-dispensed cosmeceuticals.

The increased significance of beauty and appearance, as well as expanding knowledge of anti-aging, will drive demand for cosmeceuticals prescribed by doctors. Furthermore, rising consumer awareness of the safety and efficacy of physician-dispensed cosmeceuticals, as well as a growing preference among consumers for a specific solution to different skin problems such as age spot or acne spot reduction, are expected to drive market growth significantly over the forecast period. Government regulation, intense competition, and the larger availability of replacements are some of the significant factors that might limit market growth in the anticipated time.

US Physician Dispensed Cosmeceuticals Market is poised to grow at a sustainable CAGR for the next forecast year.